Posted by Mitch on October 5, 2001, at 22:15:17
In reply to Ditto to what Noa said Scott (nm), posted by Cam W. on October 5, 2001, at 17:25:06
Cam,
Can you tell me anything new about the phase III trials that are underway for Merck's MK-869 NK-1 receptor antagonist (or anything illustrative about NK receptors role in bipolar)? I did some hunting and found this has been about since 1998 or so-but I had not been actively investigating any new meds during that time, and am quite interested since they are currently in phase III for bipolar disorder.
Thanks in advance,Mitch
poster:Mitch
thread:80156
URL: http://www.dr-bob.org/babble/20010927/msgs/80402.html